Form 4 Tracker
Esperion Therapeutics, Inc.
ESPR

15 insider filings · Latest: Jun 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 17, 2024Sep 17 8:02 PMFoody Joanne M.
Proposed Sale
3,381$1.78$6.0K

View →

Sep 17, 2024Sep 17 7:28 PMWarren Eric
Proposed Sale
2,608$1.78$4.7K

View →

Sep 17, 2024Sep 17 7:20 PMKoenig Sheldon L.
Proposed Sale
14,550$1.80$26.1K

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 16 8:20 PMBenjamin LookerChief Legal Officer
Grant/Award
269,230$2.44269,230(D)

View →

Mar 13, 2026Mar 16 8:20 PMSheldon L. KoenigDirector, President and CEO
Grant/Award
647,460$2.44647,460(D)

View →

Mar 13, 2026Mar 16 8:19 PMBenjamin HalladayChief Financial Officer
Grant/Award
221,270$2.44221,270(D)

View →